FBLG
FibroBiologics Inc

678
Mkt Cap
$17.31M
Volume
972,985.00
52W High
$1.53
52W Low
$0.2201
PE Ratio
-0.58
FBLG Fundamentals
Price
$0.254
Prev Close
$0.2559
Open
$0.247
50D MA
$0.3137
Beta
0.05
Avg. Volume
1M
EPS (Annual)
-$0.4175
P/B
2.74
Rev/Employee
$0.00
$7.56
Loading...
Loading...

About

FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
15

Frequently Asked Questions

What is Market Cap of FibroBiologics Inc?
What is the 52-week high for FibroBiologics Inc?
What is the 52-week low for FibroBiologics Inc?
What is FibroBiologics Inc stock price today?
What was FibroBiologics Inc stock price yesterday?
What is the PE ratio of FibroBiologics Inc?
What is the Price-to-Book ratio of FibroBiologics Inc?
What is the 50-day moving average of FibroBiologics Inc?
How many employees does FibroBiologics Inc have?

Latest FBLG News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.